Skip to main content

Month: May 2024

Alchip Technologies Reports Record Q1 FY2024 Revenue and Net Income

North America Accounts for 77 Percent of Revenue2024 Q1 Revenue Breakdown by RegionAlchip Technologies reported that 77 percent of its record $333.6 million first quarter 2024 revenue came from the fast-growing North America region.Taipei, Taiwan, May 16, 2024 (GLOBE NEWSWIRE) — Alchip Technologies has reported record revenue of USD$333.6 million for the first quarter of its 2024 fiscal year, topping first quarter FY2023 revenue of USD$188 million by 77.4 percent, and fourth quarter FY2023 revenue of USD$291.1 million by 14.6 percent. The Company also reported record net income for the first quarter of FY2024 of USD$39 million, up 103.9 percent over FY2023 first quarter net income of USD$19.1 million.  Earnings per share for the first quarter of FY2024 reached NT$15.8. First quarter FY2024 operating income reached USD$38.5...

Continue reading

Pulsar Helium Announces Well Works at the Jetstream #1, Topaz Project

VANCOUVER, British Columbia, May 16, 2024 (GLOBE NEWSWIRE) — Pulsar Helium Inc. (TSXV:PLSR & OTCQB:PSRHF) (“Pulsar” or the “Company”) is pleased to announce commencement of additional downhole well works at Jetstream #1 appraisal well* at its flagship Topaz helium project. Well activities are expected to occur in three phases of work activities over approximately two weeks. The initial phase will focus on additional downhole data acquisitions, followed by a second phase of wellhead and wellbore works in preparation for the final phase which consists of the flow testing and pressure build-up program. * In the State of Minnesota, the regulatory term is ‘exploratory boring’. About Pulsar Helium Inc. Pulsar Helium Inc. is a publicly traded company listed on the TSX Venture Exchange with the ticker PLSR and on the OTCQB with...

Continue reading

Macerich Announces Initial Progress in its Path Forward Strategic Plan

Macerich Purchases Remaining 40% Share of Arrowhead Towne Center (a Top 10 NOI Center for Macerich) and South Plains Mall from JV Partner, and Commits to the Sale of a Prominent Non-Mall Asset SANTA MONICA, Calif., May 16, 2024 (GLOBE NEWSWIRE) — Macerich (NYSE: MAC), one of the nation’s leading owners, operators and developers of major retail properties in top markets, today announced its purchase of the remaining 40% share of both Arrowhead Towne Center (Metro Phoenix) and South Plains Mall (Lubbock, Texas) for $36.5 million plus the debt, which for Arrowhead is a 7.2% cap rate, from its joint venture partner, a global institutional investor. This transaction, which closed on May 14, gives Macerich full ownership of both properties. Additionally, Macerich has executed a contract for the sale of an open-air asset in a major market....

Continue reading

Friends With Benefit Charity Events Partners with Eventzee for One Tree Hill Experience

20in23Friends With Benefit Charity Events partners with EventzeeTree Hill MapMap credit: Andy PhamTUSTIN, CA, May 16, 2024 (GLOBE NEWSWIRE) — Freeze Tag (OTC: FRZT), a prominent creator of location-based mobile social games, is thrilled to announce its partnership with the Friends with Benefit Charity Events (FWB). Utilizing Eventzee’s scavenger hunt app technology, FWB is hosting an immersive One Tree Hill experience in Wilmington, NC, the iconic filming location of the beloved television series.  “We’re proud to partner alongside Friends With Benefit to bring the magic of One Tree Hill to life for two decades of fans,” said Craig Holland, CEO of Freeze Tag. “Powered by Eventzee technology, Ravens fans can connect with Wilmington, NC like never before.” By utilizing Eventzee, FWB offers event...

Continue reading

Huize Holding Limited to Report First Quarter 2024 Financial Results on May 23, 2024

SHENZHEN, China, May 16, 2024 (GLOBE NEWSWIRE) — Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading digital insurance product and service platform for new generation consumers in China, today announced that it plans to release its first quarter 2024 unaudited financial results after the U.S. market closes on Thursday, May 23, 2024. The Company’s management team will hold an earnings conference call at 9:00 P.M. Eastern Time on Thursday, May 23, 2024 (9:00 A.M. Beijing/Hong Kong Time on Friday, May 24, 2024). Details for the conference call are as follows: Event Title: Huize Holding Limited’s First Quarter 2024 Earnings Conference CallRegistration Link: https://register.vevent.com/register/BI27adf75d96394227b35234de85e083b8 All participants must use the link provided above to complete the online registration...

Continue reading

iQIYI Announces First Quarter 2024 Financial Results

BEIJING, May 16, 2024 (GLOBE NEWSWIRE) — iQIYI, Inc. (Nasdaq: IQ) (“iQIYI” or the “Company”), a leading provider of online entertainment video services in China, today announced its unaudited financial results for the first quarter ended March 31, 2024. First Quarter 2024 HighlightsTotal revenues were RMB7.9 billion (US$1.1 billion1), decreasing 5% year over year. Operating income was RMB944.8 million (US$130.8 million) and operating income margin was 12%, compared to operating income of RMB858.6 million and operating income margin of 10% in the same period in 2023. Non-GAAP operating income2 was RMB1.1 billion (US$150.4 million) and non-GAAP operating income margin was 14%, compared to non-GAAP operating income of RMB1.0 billion and non-GAAP operating income margin of 12% in the same period in 2023. Net...

Continue reading

Novartis meets all tender offer conditions to acquire MorphoSys AG for EUR 68 per share in cash

Novartis secured 79.6 percent acceptance by MorphoSys shareholders during the initial acceptance period, reaching the minimum 65% acceptance threshold Settlement of the shares tendered during the initial acceptance period is expected to occur on 23 May 2024 Additional statutory acceptance period is expected to end on 30 May 2024 at 24:00 hours CEST Transaction strengthens the Novartis pipeline in oncology, adding pelabresib, a late-stage BET inhibitor for myelofibrosis and tulmimetostat, an early-stage investigational dual inhibitor of EZH2 and EZH1 for solid tumors or lymphomasBasel, 16 May 2024 – Today, Novartis BidCo AG, an (indirect) wholly owned subsidiary of Novartis AG, announced the result of its voluntary public takeover offer (the “Offer”) for the shares of MorphoSys AG (“MorphoSys”), including all shares represented by MorphoSys...

Continue reading

Havila Kystruten AS: Notice of Annual General Meeting 30 May 2024

  The Board of Directors of Havila Kystruten AS hereby gives notice of the Annual General Meeting. The meeting will take place on Thursday, 30th May 2024 at 14:00 CEST. The Annual General Meeting will be held as a digital meeting with electronic voting via Lumi platform. It is also possible to cast votes or give proxy authorizations in advance. Notice of the Annual General Meeting together with all relevant documents is available at www.havilavoyages.com/nb/ir. Further information can be found in the notice of the Annual General Meeting which is attached hereto. Contacts: Chief Executive Officer: Bent Martini, +47 905 99 650 Chief Financial Officer: Aleksander Røynesdal, +47 413 18 114    AttachmentHKY_Notice of Annual General Meeting 30 May 2024

Continue reading

Viridien (formerly CGG): Combined General Meeting and Board of Directors Meeting of May 15, 2024

Combined General Meeting and Board of Directors Meetingof May 15, 2024 Paris, France – May 16, 2024 The Combined General Meeting of Viridien (formerly CGG), presided by Mr. Philippe SALLE, Chairman of the Board of Directors, was held on May 15, 2024 in Paris. The voting results and audio replay of the event will be available on the Company’s website at the following address: https://www.cgg.com/investors/shareholder-services/general-meetings. The General Meeting adopted all resolutions that were submitted to it and notably approved the following:the statutory financial statements and consolidated financial statements for the financial year 2023;the Appointment of Ernst & Young et Autres as statutory auditors in charge of the assurance of sustainability information; the Say on Pay resolutions on the remuneration of corporate officers;...

Continue reading

Coloplast A/S – Invitation to Coloplast’s Meet the Management event on 6 June 2024 (gentle reminder)

The event will take place on Thursday, 6 June 2024 at Coloplast’s HeadquartersHoltedam 3, 3050 Humlebaek, Denmarkfrom 11.30 – 18.00 CEST (Central European Summer Time) Coloplast invites institutional investors, equity analysts and media to attend our 2024 Meet the Management event.The event will be held in person at our headquarters in Humlebaek, Denmark, with the option to join us virtually for the plenary session.The purpose of the event is to provide participants with the opportunity to meet Coloplast’s Executive Management and other members of senior management.The day will start with a plenary session, covering a brief presentation of our H1 2023/24 results, an update on our Strive25 strategy and a dedicated session on the recent acquisition of Kerecis. In the afternoon, participants will be split into groups and rotate between...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.